Analyst Consensus ?
ConsensusBuy26 ratings
Bullish1246.2%
Neutral1453.8%
Bearish00.0%
FN2 Earnings Intelligence
Raymond James Financial, Inc. (RJF) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 22, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Hold | Hold | Maintain | Sep 1, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 30, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 27, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 23, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 23, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 23, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 10, 2026 |
| Jefferies | Hold | Hold | Maintain | Apr 6, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Dec 10, 2025 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Oct 23, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 23, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Sep 22, 2025 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 11, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 3, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jul 8, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 27, 2023 |
| Seaport Global | Buy | Neutral | Upgrade | Jan 28, 2022 |
| Compass Point | Neutral | Buy | Downgrade | May 1, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Oct 26, 2018 |
| Buckingham | Buy | Buy | Maintain | Oct 26, 2018 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Feb 27, 2018 |
| Nomura | Buy | Buy | Maintain | Jul 13, 2017 |
| Macquarie | Neutral | Neutral | Maintain | Jan 22, 2016 |
| Susquehanna | Positive | Positive | Maintain | Jul 15, 2015 |
| S&P Capital IQ | Strong Buy | Buy | Upgrade | Jul 9, 2012 |
Upside is calculated against the persisted current price $165.19. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Raymond James | Analyst unavailable | $160 | $178.17 | -3.1% | Sep 1, 2026 |
| Truist Financial | David Smith | $188 | $178.17 | +13.8% | Sep 1, 2026 |
| UBS | Analyst unavailable | $184 | $172.75 | +11.4% | Jul 27, 2026 |
| Raymond James | Michael Cho | $179 | $164.91 | +8.4% | Jul 23, 2026 |
| Raymond James | Brennan Hawken | $175 | $165.16 | +5.9% | Jul 23, 2026 |
| Raymond James | Devin Ryan | $205 | $168.01 | +24.1% | Jul 23, 2026 |
| Raymond James | Analyst unavailable | $174 | $169.45 | +5.3% | Jul 10, 2026 |
| Raymond James | Analyst unavailable | $192 | $169.9 | +16.2% | Jul 9, 2026 |
| Raymond James | Analyst unavailable | $200 | $165.35 | +21.1% | Jul 9, 2026 |
| UBS | Michael Brown | $175 | $166.58 | +5.9% | Jul 8, 2026 |
| Raymond James | Analyst unavailable | $155 | $143.22 | -6.2% | May 28, 2026 |
| UBS | Analyst unavailable | $166 | $156.16 | +0.5% | Apr 23, 2026 |
| Raymond James | Analyst unavailable | $172 | $155.91 | +4.1% | Apr 23, 2026 |
| Raymond James | Michael Cyprys | $171 | $145.35 | +3.5% | Apr 10, 2026 |
| Raymond James | Analyst unavailable | $156 | $148.14 | -5.6% | Apr 9, 2026 |
| Raymond James | Analyst unavailable | $165 | $147.82 | -0.1% | Apr 8, 2026 |
| UBS | Analyst unavailable | $158 | $147.82 | -4.4% | Apr 8, 2026 |
| Raymond James | Analyst unavailable | $198 | $165.86 | +19.9% | Feb 1, 2026 |
| Raymond James | Analyst unavailable | $191 | $169.02 | +15.6% | Jan 28, 2026 |
| Raymond James | Michael Cyprys | $187 | $163.01 | +13.2% | Dec 22, 2025 |
| UBS | Michael Brown | $176 | $166.94 | +6.5% | Dec 11, 2025 |
| Raymond James | Analyst unavailable | $196 | $165.79 | +18.7% | Dec 10, 2025 |
| Raymond James | Analyst unavailable | $194 | $164.98 | +17.4% | Oct 23, 2025 |
| Raymond James | Brennan Hawken | $182 | $166.04 | +10.2% | Oct 23, 2025 |
| Raymond James | Analyst unavailable | $181 | $166.04 | +9.6% | Oct 23, 2025 |
| Raymond James | Devin Ryan | $190 | $162.06 | +15.0% | Oct 23, 2025 |
| Raymond James | Devin Ryan | $185 | $165.15 | +12.0% | Oct 9, 2025 |
| Raymond James | Analyst unavailable | $178 | $167.64 | +7.8% | Oct 7, 2025 |
| Raymond James | Analyst unavailable | $173 | $165.9 | +4.7% | Oct 2, 2025 |
| Raymond James | Analyst unavailable | $184 | $168.6 | +11.4% | Oct 1, 2025 |
| Raymond James | Devin Ryan | $180 | $159.31 | +9.0% | Jul 14, 2025 |
| Raymond James | Craig Siegenthaler | $159 | $137.26 | -3.7% | Apr 24, 2025 |
| Raymond James | Analyst unavailable | $161 | $144.19 | -2.5% | Mar 4, 2025 |
| Raymond James | Christopher Allen | $170 | $154.21 | +2.9% | Jan 10, 2025 |
| Raymond James | William Kirk | $150 | $149.05 | -9.2% | Oct 30, 2024 |
| Raymond James | Michael Cyprys | $132 | $136.51 | -20.1% | Oct 17, 2024 |
| Raymond James | Devin Ryan | $146 | $124.9 | -11.6% | Oct 9, 2024 |
| Wells Fargo | Christopher Harris | $138 | $115.95 | -16.5% | Sep 11, 2024 |
| Raymond James | Daniel Fannon | $123 | $119.51 | -25.5% | Jul 8, 2024 |
| Raymond James | William Kirk | $130 | $125.36 | -21.3% | May 24, 2024 |
| Raymond James | Bill Katz | $126 | $123.39 | -23.7% | May 24, 2024 |
| Seaport Global | Jim Mitchell | $139 | $129.61 | -15.9% | Apr 4, 2024 |
| Raymond James | Mark McLaughlin | $145 | $128.43 | -12.2% | Apr 2, 2024 |
| Raymond James | Mark McLaughlin | $122 | $106.83 | -26.1% | Sep 11, 2023 |
| UBS | Analyst unavailable | $125 | $110.71 | -24.3% | Jan 9, 2023 |
| Raymond James | Analyst unavailable | $130.07 | $67.71 | -21.3% | Apr 29, 2022 |
| Morgan Stanley | Manan Gosalia | $128 | $98.45 | -22.5% | Mar 14, 2022 |
Track every rating change on RJF the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.